Sort
53,477 grants matching “addiction”
Mechanisms of Ethnic/Racial Differences in Lung Cancer Due to Cigarette Smoking
$2,093,424Stephen S Hecht · University Of Minnesota · P01 · FY2024 · CA
Preclinical Medications Discovery and Abuse Liability Testing
$2,092,943Louis Harris · Virginia Commonwealth University · N01 · FY2010 · DA
Optogenetics and Transgenic Technology Core
$2,092,870Brandon Harvey · National Institute On Drug Abuse · ZIC · FY2016 · DA
A novel oral immunotherapy for chronic visceral pain of irritable bowel syndrome
$2,091,549Zhiyong Yang · Fzata, Inc. · UG3 · FY2024 · NS
Centers for Cancer Systems Therapeutics (CaST)
$2,090,840Andrea Califano · Columbia University Health Sciences · U54 · FY2018 · CA
EFFECTS OF NICOTINE YIELD & NICOTINE REPLACEMENT ON VERY LOW NICOTINE CONTENT CIGARETTES
$2,090,519Eric Christian Donny · University Of Pittsburgh At Pittsburgh · U54 · FY2015 · DA
NOVEL MEDICATION APPROACHES FOR SUBSTANCE ABUSE
$2,089,914New York State Psychiatric Institute · P50 · FY2003 · DA
Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid Receptors
$2,089,368Kenner Rice · National Institute On Drug Abuse · Z01 · FY2008 · DA
Procurement and Characterization of Postmortem Brain Tissue
$2,089,295Joel Kleinman · National Institute Of Mental Health · Z01 · FY2008 · MH
TRANSDISCIPLINARY TOBACCO USE RESEARCH CENTERS
$2,087,995University Of Pennsylvania · P50 · FY2002 · CA
ENIGMA Center for Worldwide Medicine, Imaging & Genomics
$2,087,641Paul M Thompson · University Of Southern California · U54 · FY2014 · EB
Massachusetts Justice Community Opioid Innovation Network (JCOIN) Clinical Research Center
$2,086,717Peter D. Friedmann · Baystate Medical Center, Inc. · UG1 · FY2019 · DA
Development of MRI Techniques for Drug-Abuse Applications
$2,086,516Yihong Yang · National Institute On Drug Abuse · ZIA · FY2009 · DA
Advancing the Development of a Humanized Anti-cocaine Monoclonal Antibody
$2,086,019Andrew B Norman · University Of Cincinnati · U01 · FY2017 · DA
Transition to Human Phase 1b Trials: Nonclinical Studies of an Anti-METH mAb
$2,085,133Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2016 · DA
Using Implementation Interventions and Peer Recovery Support to Improve Opioid Treatment Outcomes in Community Supervision
$2,083,986Rosemarie A Martin · Brown University · U01 · FY2022 · DA
Neurotoxicity in the adult rat following chronic exposure to methamphetamine
$2,083,928Jean Lud Cadet · National Institute On Drug Abuse · ZIA · FY2013 · DA
Effects of Public Information in Cancer (EPIC Center)
$2,083,270University Of Pennsylvania · P50 · FY2005 · CA
Rat Genome Database
$2,081,534Anne E. Kwitek · Medical College Of Wisconsin · R01 · FY2022 · HL
HEAL Sickle Cell and CDE Supplement
$2,081,355Jonathan Michael Dean · University Of Utah · U24 · FY2023 · TR
Transdermal Cannabinoid Prodrug Treatment for Cannabis Withdrawal and Dependence
$2,080,746Audra L Stinchcomb · Alltranz, Inc. · RC2 · FY2009 · DA
Causal Inference Methods for HIV Prevention Studies Among Networks of People Who Use Drugs
$2,080,476Ashley Lynn Buchanan · University Of Rhode Island · DP2 · FY2018 · DA
Emory-MSSM-GSK-NIMH Collaborative Mood and Anxiety Disorders Initiative
$2,080,338Helen S Mayberg · Emory University · U19 · FY2012 · MH
INTERACTIONS BETWEEN NICOTINE & OTHER CIGARETTE SMOKE COMPONENTS IN SUPPORTING
$2,080,211Alan F Sved · University Of Pittsburgh At Pittsburgh · U54 · FY2015 · DA
Development of MMP-9 inhibitory monoclonal antibodies to relieve neuropathic pain
$2,079,796Xin Ge · University Of Texas Hlth Sci Ctr Houston · UG3 · FY2025 · NS